rs144653976
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting
The NM_005045.4(RELN):c.2446C>T(p.Leu816Phe) variant causes a missense change. The variant allele was found at a frequency of 0.000358 in 1,613,770 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005045.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152092Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000191 AC: 48AN: 250962Hom.: 0 AF XY: 0.000192 AC XY: 26AN XY: 135628
GnomAD4 exome AF: 0.000366 AC: 535AN: 1461678Hom.: 0 Cov.: 32 AF XY: 0.000358 AC XY: 260AN XY: 727148
GnomAD4 genome AF: 0.000283 AC: 43AN: 152092Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74282
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Norman-Roberts syndrome;C4225327:Familial temporal lobe epilepsy 7;C4551957:Epilepsy, familial temporal lobe, 1 Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.2446C>T (p.L816F) alteration is located in exon 19 (coding exon 19) of the RELN gene. This alteration results from a C to T substitution at nucleotide position 2446, causing the leucine (L) at amino acid position 816 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
RELN-related disorder Uncertain:1
The RELN c.2446C>T variant is predicted to result in the amino acid substitution p.Leu816Phe. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.040% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Norman-Roberts syndrome;C4225327:Familial temporal lobe epilepsy 7 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at